Recursion Pharmaceuticals, Inc.
Shows how much buzz exceeds trading volume.
30-Day Trend
RXRX (Recursion Pharmaceuticals, Inc.) is ranked #40 on the All Score, up from #51 (+11) across StockTwits, Korea, China, Germany, and Japan retail investor sources.
Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here’s What You Should Know
Benzinga · Oct 16, 2026
Recursion (RXRX) Enters New Growth Phase as Sanofi Kicks Off Drug Collab, Shares Soar
Yahoo · Oct 15, 2026
Sanofi (ENXTPA:SAN) Adds AI Immunology Candidate As Fair Value Questions Persist
Yahoo · Oct 15, 2026
RXRX Stock Heads For Its Best Day In Over A Year – What’s Driving The Rally Today?
Yahoo · Oct 15, 2026
Recursion: Maintaining 'Hold' On REC-4881 End 2026 Program Update And Collaboration Candidates In Play
SeekingAlpha · Oct 15, 2026
US market headlines from third-party sources. Updated daily.
Updated
